Abstract
Grazoprevir (GZR) and elbasvir (EBR) are indicated for the treatment of chronic hepatitis C infection. The natural history of HCV infection, especially the development of cirrhosis and its complications, are covered in Chapter 261, Protease, polymerase, and assembly inhibitors for the treatment of hepatitis C virus infection, and the use of these antiviral agents should be considered in that context.
| Original language | English |
|---|---|
| Title of host publication | Kucers the Use of Antibiotics |
| Subtitle of host publication | A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs |
| Publisher | CRC Press |
| Pages | 4510-4519 |
| Number of pages | 10 |
| Edition | 7th |
| ISBN (Electronic) | 9781498747967 |
| ISBN (Print) | 9781498747950 |
| Publication status | Published - 2 Oct 2017 |
